ECI Biotech

ECI Biotech, Inc. (ECI) is a premier developer and manufacturer of innovative, patented ExpressDetect® sensors for rapid infection determination at the point-of-care (PoC) for professional use, as well as consumer OTC markets. Our infection sensor diagnostics can be incorporated into any medical device or consumer product and will ultimately transform the way pathogens are detected in wound care, women's health, baby care and oral care.

Our goal is to promote healing and improve the quality of patient health through the development of affordable and simple diagnostics. ECI Biotech has established partnerships with leading medical device and consumer product companies to bring innovative discoveries to market on a global scale.
ECI Biotech has a dominant patent portfolio that includes diagnostics, therapeutics, and advance molecular technologies.

ECI's proprietary diagnostic technologies incorporate both specific and broad-spectrum targets for detection of microbial pathogens that are derived from genomic studies and high throughput library screening (HTS). The detection platform includes simple consumer grade sensors for bacterial monitoring, rapid enzyme-linked (zymogen) sensors for point-of-care use, and ultra-sensitive sensors for the remote detection of microbes.